Repository logo
Andean Publishing ↗
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Autor "Gabriel Jaime Murillo Arango"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item type: Item ,
    Antiprotozoal activities of Colombian plants
    (Elsevier BV, 2001) Bernard Weniger; Sara M. Robledo; Gabriel Jaime Murillo Arango; Eric Deharo; Raúl Aragón; Victoria Muñoz; Jorgia Callapa; Annelise Lobstein; Robert Anton
  • Loading...
    Thumbnail Image
    Item type: Item ,
    Antiprotozoal and cytotoxic activities in vitro of Colombian Annonaceae
    (Elsevier BV, 2007) Edison Osorio; Gabriel Jaime Murillo Arango; Nora Jiménez; Fernando Álzate; Grace Ruiz; David Gutiérrez; Marco Antonio Paco; Alberto Giménez; Sara M. Robledo
  • Loading...
    Thumbnail Image
    Item type: Item ,
    Avtividad antiplamódica in vitro e inhibición de la formación de la beta-hematina de plantas colombianas de la familia Annonaceae
    (2005) Edison Osorio; Gabriel Jaime Murillo Arango; Edison Parra; Katalina Muñoz-Durango; Grace Ruiz; David Gutiérrez; Marco Antonio Paco; Alberto Giménez
  • Loading...
    Thumbnail Image
    Item type: Item ,
    In Vitro and In Vivo Cytotoxicities and Antileishmanial Activities of Thymol and Hemisynthetic Derivatives
    (American Society for Microbiology, 2005) Sara M. Robledo; Edison Osorio; Diana L. Muñoz; Luz Jaramillo; Adriana Restrepo; Gabriel Jaime Murillo Arango; Iván Darío Vélez
    The in vitro and in vivo antileishmanial and cytotoxic activities of thymol and structural derivatives in comparison to those of Glucantime were studied. The results showed here suggest that thymol and hemisynthetic derivatives have promising antileishmanial potential and could be considered as new lead structures in the search for novel antileishmanial drugs.

Andean Library © 2026 · Andean Publishing

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback